[2]
Almassi N, Bochner BH. Ileal conduit or orthotopic neobladder: selection and contemporary patterns of use. Current opinion in urology. 2020 May:30(3):415-420. doi: 10.1097/MOU.0000000000000738. Epub
[PubMed PMID: 32141937]
Level 3 (low-level) evidence
[3]
Moschini M, Arbelaez E, Cornelius J, Mattei A, Shariat SF, Dell Oglio P, Zaffuto E, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A. Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer. Urologic oncology. 2018 Jun:36(6):307.e9-307.e14. doi: 10.1016/j.urolonc.2018.03.002. Epub 2018 Mar 27
[PubMed PMID: 29602638]
[4]
Hwang EC, Sathianathen NJ, Imamura M, Kuntz GM, Risk MC, Dahm P. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy. The Cochrane database of systematic reviews. 2019 May 14:5(5):CD013336. doi: 10.1002/14651858.CD013336. Epub 2019 May 14
[PubMed PMID: 31111956]
Level 1 (high-level) evidence
[5]
Dorin RP, Skinner EC. Extended lymphadenectomy in bladder cancer. Current opinion in urology. 2010 Sep:20(5):414-20. doi: 10.1097/MOU.0b013e32833c9194. Epub
[PubMed PMID: 20657290]
Level 3 (low-level) evidence
[6]
Spector DA, Deng J, Stewart KJ. Hydration status affects sodium, potassium, and chloride transport across rat urothelia. American journal of physiology. Renal physiology. 2013 Dec 15:305(12):F1669-79. doi: 10.1152/ajprenal.00353.2013. Epub 2013 Aug 28
[PubMed PMID: 23986521]
[7]
Mann R, Mediati DG, Duggin IG, Harry EJ, Bottomley AL. Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract. Frontiers in cellular and infection microbiology. 2017:7():241. doi: 10.3389/fcimb.2017.00241. Epub 2017 Jun 8
[PubMed PMID: 28642845]
[8]
Crawford JM. The origins of bladder cancer. Laboratory investigation; a journal of technical methods and pathology. 2008 Jul:88(7):686-93. doi: 10.1038/labinvest.2008.48. Epub 2008 May 12
[PubMed PMID: 18475256]
[9]
Hugen CM, Daneshmand S. Lymph node dissection in bladder cancer: Where do we stand? World journal of urology. 2017 Apr:35(4):527-533. doi: 10.1007/s00345-015-1751-9. Epub 2015 Dec 28
[PubMed PMID: 26712616]
[10]
Briganti A, Gandaglia G, Scuderi S, Gallina A, Colombo R, Fossati N, Barletta F, Pellegrino A, Nocera L, Montorsi F, Necchi A. Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial. European urology. 2020 May:77(5):576-580. doi: 10.1016/j.eururo.2019.12.019. Epub 2020 Jan 3
[PubMed PMID: 31911010]
[11]
Kiss B, Paerli M, Schöndorf D, Burkhard FC, Thalmann GN, Roth B. Pelvic Lymph Node Dissection may be Limited on the Contralateral Side in Strictly Unilateral Bladder Cancer without Compromising Oncological Radicality. Bladder cancer (Amsterdam, Netherlands). 2016 Jan 7:2(1):53-59
[PubMed PMID: 27376125]
[12]
Gupta A, Atoria CL, Ehdaie B, Shariat SF, Rabbani F, Herr HW, Bochner BH, Elkin EB. Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Oct 10:32(29):3291-8. doi: 10.1200/JCO.2013.54.3173. Epub 2014 Sep 2
[PubMed PMID: 25185104]
[13]
Pietzak EJ, Donahue TF, Bochner BH. Male Neobladder. The Urologic clinics of North America. 2018 Feb:45(1):37-48. doi: 10.1016/j.ucl.2017.09.003. Epub
[PubMed PMID: 29169449]
[14]
Chang SS, Alberts GL, Smith JA Jr, Cookson MS. Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation. World journal of urology. 2004 Oct:22(4):272-6
[PubMed PMID: 15448995]
[15]
Hansen MH, Hayn M, Murray P. The Use of Bowel in Urologic Reconstructive Surgery. The Surgical clinics of North America. 2016 Jun:96(3):567-82. doi: 10.1016/j.suc.2016.02.011. Epub
[PubMed PMID: 27261795]
[16]
Roth JD, Koch MO. Metabolic and Nutritional Consequences of Urinary Diversion Using Intestinal Segments to Reconstruct the Urinary Tract. The Urologic clinics of North America. 2018 Feb:45(1):19-24. doi: 10.1016/j.ucl.2017.09.007. Epub
[PubMed PMID: 29169447]
[17]
Almassi N, Cha EK, Vertosick EA, Huang C, Wong N, Dason S, McPherson V, Dean L, Benfante N, Sjoberg DD, Rosenberg JE, Bajorin DF, Herr HW, Dalbagni G, Bochner BH. Trends in Management and Outcomes among Patients with Urothelial Carcinoma Undergoing Radical Cystectomy from 1995 to 2015: The Memorial Sloan Kettering Experience. The Journal of urology. 2020 Oct:204(4):677-684. doi: 10.1097/JU.0000000000001071. Epub 2020 Apr 15
[PubMed PMID: 32294398]
[18]
Daneshmand S, Bartsch G. Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Expert review of anticancer therapy. 2011 Jun:11(6):941-8. doi: 10.1586/era.11.19. Epub
[PubMed PMID: 21707291]
[19]
Pearce SM, Daneshmand S. Continent Cutaneous Diversion. The Urologic clinics of North America. 2018 Feb:45(1):55-65. doi: 10.1016/j.ucl.2017.09.004. Epub
[PubMed PMID: 29169451]
[20]
Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, Raj G, Bochner BH, Dalbagni G, Herr HW, Donat SM. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. European urology. 2009 Jan:55(1):164-74. doi: 10.1016/j.eururo.2008.07.031. Epub 2008 Jul 18
[PubMed PMID: 18675501]
[21]
Nagele U, Anastasiadis AG, Stenzl A, Kuczyk M. Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results. World journal of urology. 2012 Dec:30(6):725-32. doi: 10.1007/s00345-011-0649-4. Epub 2011 Feb 5
[PubMed PMID: 21298273]
Level 2 (mid-level) evidence
[22]
Zlatev DV, Skinner EC. Orthotopic Urinary Diversion for Women. The Urologic clinics of North America. 2018 Feb:45(1):49-54. doi: 10.1016/j.ucl.2017.09.005. Epub
[PubMed PMID: 29169450]
[23]
Chopra S, Abreu AL, Gill IS. Robotic urinary diversion: the range of options. Current opinion in urology. 2016 Jan:26(1):107-13. doi: 10.1097/MOU.0000000000000248. Epub
[PubMed PMID: 26574875]
Level 3 (low-level) evidence
[24]
Lee DJ, Tyson MD, Chang SS. Conduit Urinary Diversion. The Urologic clinics of North America. 2018 Feb:45(1):25-36. doi: 10.1016/j.ucl.2017.09.006. Epub
[PubMed PMID: 29169448]
[25]
Bochner BH, Figueroa AJ, Skinner EC, Lieskovsky G, Petrovich Z, Boyd SD, Skinner DG. Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. The Journal of urology. 1998 Jul:160(1):29-33
[PubMed PMID: 9628599]
[26]
Check DK, Leo MC, Banegas MP, Bulkley JE, Danforth KN, Gilbert SM, Kwan ML, Rosetti MO, McMullen CK. Decision Regret Related to Urinary Diversion Choice among Patients Treated with Cystectomy. The Journal of urology. 2020 Jan:203(1):159-163. doi: 10.1097/JU.0000000000000512. Epub 2019 Aug 23
[PubMed PMID: 31441673]
[27]
Leo MC, Gilbert SM, Wendel CS, Krouse RS, Grant M, Danforth KN, Kwan ML, Harrison TN, Bulkley JE, McMullen CK. Development of a Goal Elicitation Measure to Support Choice about Urinary Diversion by Patients with Bladder Cancer. The Journal of urology. 2019 Jul:202(1):83-89. doi: 10.1097/JU.0000000000000203. Epub 2019 Jun 7
[PubMed PMID: 30835627]
[28]
Lauridsen SV, Thomsen T, Kaldan G, Lydom LN, Tønnesen H. Smoking and alcohol cessation intervention in relation to radical cystectomy: a qualitative study of cancer patients' experiences. BMC cancer. 2017 Nov 25:17(1):793. doi: 10.1186/s12885-017-3792-5. Epub 2017 Nov 25
[PubMed PMID: 29178899]
Level 2 (mid-level) evidence
[29]
Lambert JW, Ingham M, Gibbs BB, Given RW, Lance RS, Riggs SB. Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer. Urology. 2013 Mar:81(3):587-92. doi: 10.1016/j.urology.2012.10.055. Epub 2013 Jan 24
[PubMed PMID: 23352372]
[30]
Johnson DC, Riggs SB, Nielsen ME, Matthews JE, Woods ME, Wallen EM, Pruthi RS, Smith AB. Nutritional predictors of complications following radical cystectomy. World journal of urology. 2015 Aug:33(8):1129-37. doi: 10.1007/s00345-014-1409-z. Epub 2014 Sep 21
[PubMed PMID: 25240535]
[31]
Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009 Jan 1:115(1):68-74. doi: 10.1002/cncr.23986. Epub
[PubMed PMID: 19072984]
[32]
Galsky MD. How I treat bladder cancer in elderly patients. Journal of geriatric oncology. 2015 Jan:6(1):1-7. doi: 10.1016/j.jgo.2014.11.006. Epub 2014 Dec 4
[PubMed PMID: 25482022]
[33]
Maffezzini M, Campodonico F, Canepa G, Gerbi G, Parodi D. Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus. Surgical oncology. 2008 Jul:17(1):41-8
[PubMed PMID: 17962014]
[34]
Sultan S, Coles B, Dahm P. Alvimopan for recovery of bowel function after radical cystectomy. The Cochrane database of systematic reviews. 2017 May 2:5(5):CD012111. doi: 10.1002/14651858.CD012111.pub2. Epub 2017 May 2
[PubMed PMID: 28462518]
Level 1 (high-level) evidence
[35]
Keane PF, Bonner MC, Johnston SR, Zafar A, Gorman SP. Characterization of biofilm and encrustation on ureteric stents in vivo. British journal of urology. 1994 Jun:73(6):687-91
[PubMed PMID: 8032837]
[36]
Mattei A, Birkhaeuser FD, Baermann C, Warncke SH, Studer UE. To stent or not to stent perioperatively the ureteroileal anastomosis of ileal orthotopic bladder substitutes and ileal conduits? Results of a prospective randomized trial. The Journal of urology. 2008 Feb:179(2):582-6
[PubMed PMID: 18078958]
Level 1 (high-level) evidence
[37]
Lamb BW, Tan WS, Eneje P, Bruce D, Jones A, Ahmad I, Sridhar A, Baker H, Briggs TP, Hines JE, Nathan S, Martin D, Stephens RC, Kelly JD. Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: A prospective cohort study. Urologic oncology. 2016 Sep:34(9):417.e17-23. doi: 10.1016/j.urolonc.2016.04.006. Epub 2016 May 16
[PubMed PMID: 27197920]
[38]
Anderson CB, McKiernan JM. Surgical Complications of Urinary Diversion. The Urologic clinics of North America. 2018 Feb:45(1):79-90. doi: 10.1016/j.ucl.2017.09.008. Epub
[PubMed PMID: 29169453]
[39]
Nazmy M, Yuh B, Kawachi M, Lau CS, Linehan J, Ruel NH, Torrey RR, Yamzon J, Wilson TG, Chan KG. Early and late complications of robot-assisted radical cystectomy: a standardized analysis by urinary diversion type. The Journal of urology. 2014 Mar:191(3):681-7. doi: 10.1016/j.juro.2013.10.022. Epub 2013 Oct 4
[PubMed PMID: 24099746]
[40]
Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. The Journal of urology. 2010 Sep:184(3):990-4; quiz 1235. doi: 10.1016/j.juro.2010.05.037. Epub
[PubMed PMID: 20643429]
[41]
Desai MM, Simone G, de Castro Abreu AL, Chopra S, Ferriero M, Guaglianone S, Minisola F, Park D, Sotelo R, Gallucci M, Gill IS, Aron M. Robotic Intracorporeal Continent Cutaneous Diversion. The Journal of urology. 2017 Aug:198(2):436-444. doi: 10.1016/j.juro.2017.01.091. Epub 2017 Mar 21
[PubMed PMID: 28336308]
[42]
Lawrentschuk N, Colombo R, Hakenberg OW, Lerner SP, Månsson W, Sagalowsky A, Wirth MP. Prevention and management of complications following radical cystectomy for bladder cancer. European urology. 2010 Jun:57(6):983-1001. doi: 10.1016/j.eururo.2010.02.024. Epub 2010 Feb 26
[PubMed PMID: 20227172]
[43]
Schomburg J, Krishna S, Soubra A, Cotter K, Fan Y, Brown G, Konety B. Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy. Urologic oncology. 2018 Feb:36(2):77.e9-77.e13. doi: 10.1016/j.urolonc.2017.09.029. Epub 2017 Oct 31
[PubMed PMID: 29097086]
[44]
Bochner BH, Dalbagni G, Marzouk KH, Sjoberg DD, Lee J, Donat SM, Coleman JA, Vickers A, Herr HW, Laudone VP. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. European urology. 2018 Oct:74(4):465-471. doi: 10.1016/j.eururo.2018.04.030. Epub 2018 May 18
[PubMed PMID: 29784190]
Level 1 (high-level) evidence
[45]
Bricker EM. Bladder substitution after pelvic evisceration. 1950. The Journal of urology. 2002 Feb:167(2 Pt 2):1140-5; discussion 1146
[PubMed PMID: 11905889]
[46]
Simone G, Papalia R, Misuraca L, Tuderti G, Minisola F, Ferriero M, Vallati G, Guaglianone S, Gallucci M. Robotic Intracorporeal Padua Ileal Bladder: Surgical Technique, Perioperative, Oncologic and Functional Outcomes. European urology. 2018 Jun:73(6):934-940. doi: 10.1016/j.eururo.2016.10.018. Epub 2016 Oct 22
[PubMed PMID: 27780643]
[47]
Cho A, Lee SM, Noh JW, Choi DK, Lee Y, Cho ST, Kim KK, Lee YG, Lee YK. Acid-base disorders after orthotopic bladder replacement: comparison of an ileal neobladder and an ileal conduit. Renal failure. 2017 Nov:39(1):379-384. doi: 10.1080/0886022X.2017.1287733. Epub
[PubMed PMID: 28209079]
[48]
Reddy M, Kader K. Follow-up Management of Cystectomy Patients. The Urologic clinics of North America. 2018 May:45(2):241-247. doi: 10.1016/j.ucl.2018.01.001. Epub
[PubMed PMID: 29650139]
[49]
Udovicich C, Perera M, Huq M, Wong LM, Lenaghan D. Hospital volume and perioperative outcomes for radical cystectomy: a population study. BJU international. 2017 May:119 Suppl 5():26-32. doi: 10.1111/bju.13827. Epub
[PubMed PMID: 28544301]
[50]
Afshar M, Goodfellow H, Jackson-Spence F, Evison F, Parkin J, Bryan RT, Parsons H, James ND, Patel P. Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation. BJU international. 2018 Feb:121(2):217-224. doi: 10.1111/bju.13929. Epub 2017 Jul 10
[PubMed PMID: 28594471]
Level 3 (low-level) evidence
[51]
Cerantola Y, Valerio M, Persson B, Jichlinski P, Ljungqvist O, Hubner M, Kassouf W, Muller S, Baldini G, Carli F, Naesheimh T, Ytrebo L, Revhaug A, Lassen K, Knutsen T, Aarsether E, Wiklund P, Patel HR. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations. Clinical nutrition (Edinburgh, Scotland). 2013 Dec:32(6):879-87. doi: 10.1016/j.clnu.2013.09.014. Epub 2013 Oct 17
[PubMed PMID: 24189391]
[52]
Pittman J, Rawl SM, Schmidt CM, Grant M, Ko CY, Wendel C, Krouse RS. Demographic and clinical factors related to ostomy complications and quality of life in veterans with an ostomy. Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society. 2008 Sep-Oct:35(5):493-503. doi: 10.1097/01.WON.0000335961.68113.cb. Epub
[PubMed PMID: 18794701]
Level 2 (mid-level) evidence
[53]
Salvadalena G, Hendren S, McKenna L, Muldoon R, Netsch D, Paquette I, Pittman J, Ramundo J, Steinberg G. WOCN Society and AUA Position Statement on Preoperative Stoma Site Marking for Patients Undergoing Urostomy Surgery. Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society. 2015 May-Jun:42(3):253-6. doi: 10.1097/WON.0000000000000118. Epub
[PubMed PMID: 25695928]
[54]
Park JJ, Del Pino A, Orsay CP, Nelson RL, Pearl RK, Cintron JR, Abcarian H. Stoma complications: the Cook County Hospital experience. Diseases of the colon and rectum. 1999 Dec:42(12):1575-80
[PubMed PMID: 10613476]